Cart
sales@molnova.com
SF5
CAS No. 34634-22-5
SF5 ( SF-5; SF 5; 2,2-Diphenylethylisothiocyanate )
Catalog No. M27794 CAS No. 34634-22-5
SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 500MG | 3348 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSF5
-
NoteResearch use only, not for human use.
-
Brief DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
-
DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.(In Vitro):SF5 shows strong cell survival effect of kidney epithelial cells (93% at a concentration of 2.5 μM).
-
SynonymsSF-5; SF 5; 2,2-Diphenylethylisothiocyanate
-
PathwayApoptosis
-
TargetApoptosis
-
Recptorribonucleotide reductase(RR);Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number34634-22-5
-
Formula Weight239.3
-
Molecular FormulaC15H13NS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C=NCC(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Larsen IK, et al. Caracemide, a site-specific irreversible inhibitor of protein R1 of Escherichia coli ribonucleotide reductase. J Biol Chem. 1992 Jun 25;267(18):12627-31.
molnova catalog
related products
-
Inecalcitol
Inecalcitol is the growth inhibitor of human breast cancer cells. Inecalcitol is a unique vitamin D3 analog with Kd of 0.53 nM.
-
2,5-dimethyl Celecox...
2,5-dimethyl Celecoxib is a celecoxib derivative and a targeted inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1), a key enzyme in the PGE2 synthesis pathway of inflammatory mediators.
-
Cl-amidine hydrochlo...
Cl-amidine hydrochloride is an orally active peptidylarginine deminase (PAD) inhibitor (IC50: 5.9 μM for PAD4).
